15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 11 firms covering Solventum Corp, 7 rate it Buy or better, 3 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $60.00 to $105.00, a moderate spread. The average target of $90.45 is roughly in line with the current $90.16. The rating mix has stayed broadly stable, with Buy-side ratings easing from 8 to 7 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.79 next quarter toward $7.22 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 ratings
Moderate Buy
Strong Buy00%
Buy764%
Hold327%
Sell19%
Strong Sell00%
Based on 11 analysts giving stock ratings to Solventum Corp.
As of Sep, 7 of 10 firms rate SOLV a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
SOLV EPS & revenue forecast
EPS · NEXT QUARTER
$1.79
Range $1.74 – $1.90 · 11 analysts · +14% YoY
Next period, 11 analysts expect Solventum Corp. to earn $1.79 a share (range $1.74 – $1.90), versus $1.57 a year earlier. Full-year consensus is $7.18, growing to $7.22 the year after.
REVENUE · NEXT QUARTER
$2.1B
Range $2.1B – $2.1B · 11 analysts · +5% YoY
Revenue is expected to reach $2.1B (range $2.1B – $2.1B), +4.5% year-over-year. Full-year consensus is $8.2B, rising to $8.5B next year.
Top analysts covering Solventum Corp.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SOLV.
#1
Jason Bednar
Piper Sandler · Rank #276
Buy
$105.00+16.5% to target
Overall win rate
35%
+ Follow
#2
Brett Fishbin
KeyBanc
Buy
$102.00+13.1% to target
Coverage
—
+ Follow
#3
Kevin Caliendo
UBS
Buy
$101.00+12.0% to target
Coverage
—
+ Follow
#4
Rick Wise
Stifel
Buy
$100.00+10.9% to target
Coverage
—
+ Follow
#5
Ryan Zimmerman
BTIG
Buy
$95.00+5.4% to target
Coverage
—
+ Follow
SOLV stock forecast FAQ
What is SOLV's average 12-month price target?+
The 10 analysts with a live target average $90.45 for Solventum Corp. over the next 12 months, ranging from a $105.00 high to a $60.00 low.
Is SOLV stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 11 analyst ratings, 7 are Buy or Strong Buy, 3 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for SOLV?+
The Street-high target is $105.00 (Piper Sandler), and the Street-low is $60.00 (Rothschild & Co). The average of all 10 active targets is $90.45.
How many Wall Street analysts cover SOLV?+
11 analysts have an active rating on Solventum Corp., and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering SOLV?+
Among analysts who currently cover SOLV, Jason Bednar of Piper Sandler has the strongest overall Quantellect track record (Rank #276). Their current call is Buy with a $105.00 target.
What is Solventum Corp.'s projected EPS for next quarter?+
The consensus estimate is $1.79 per share (range $1.74 – $1.90) across 11 analysts. Full-year EPS is projected at $7.18, rising to $7.22 the following year.
How much revenue is Solventum Corp. expected to report next quarter?+
Consensus revenue is $2.1B (range $2.1B – $2.1B). Full-year revenue is projected at $8.2B, growing to $8.5B next year.
Have analysts been upgrading or downgrading SOLV lately?+
As of Sep, 7 of 10 firms rate SOLV a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SOLV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
